Dental and Medical Problems

Dent Med Probl
Index Copernicus (ICV 2020) – 128.41
MEiN – 70 pts
CiteScore (2021) – 2.0
JCI – 0.5
Average rejection rate (2021) – 81.35%
ISSN 1644-387X (print)
ISSN 2300-9020 (online)
Periodicity – quarterly

Download PDF

Dental and Medical Problems

2017, vol. 54, nr 1, January-March, p. 67–71

doi: 10.17219/dmp/65450

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Creative Commons BY-NC-ND 3.0 Open Access

Oral hygiene in children with epilepsy: Effect of interleukin-1β and VEGF levels in gingival crevicular fluid

Higiena jamy ustnej dzieci chorych na epilepsję a stężenie interleukiny 1β i czynnika wzrostu naczyniowo-śródbłonkowego w płynie dziąsłowym

Gülsüm Duruk1,A,B,C,D,E,F, Hulya Aksoy2,A,B,C,D, Taskın Gurbuz3,A,B,C, Esra Laloglu4,A,B, Huseyin Tan5,A,B

1 Inonu University, Faculty of Dentistry, Department of Pediatric Dentistry, Malatya, Turkey

2 Private Medical Practice, Erzurum, Turkey

3 Ataturk University, Faculty of Dentistry, Department of Pediatric Dentistry, Erzurum, Turkey

4 Ataturk University, Faculty of Medicine, Department of Biochemistry, Erzurum, Turkey

5 Ataturk University, Faculty of Medicine, Department of Pediatric Neurology, Erzurum, Turkey

Abstract

Background. The biochemical parameters in gingival crevicular fluid (GCF) are affected by some systemic diseases and poor oral hygiene.
Objectives. The aim of this study was to evaluate the total amounts of Interleukin-1β (IL-1β) and vascular endothelial growth factor (VEGF) in GCF in children with epilepsy.
Material and Methods. Eighty children with epilepsy in a seizure-free period (the test group) and 80 healthy children (the control group) were evaluated. The children with epilepsy were taking valproic acid (VPA), carbamazepine, phenobarbital, and the combinations of these drugs. Gingival index (GI), plaque index (PI), probing depth (PD) and clinical attachment level (CAL) were measured. GCF was collected and its volume was measured. The total amounts of IL-1β and VEGF in the GCF were analyzed in the Biochemistry Laboratory at Ataturk University.
Results. The biochemical (IL-1β and VEGF) and clinical parameters (GI, PI, PD and GCF volume) were significantly higher in children with epilepsy compared to healthy children (p < 0.0001). When the epilepsy patients were divided into groups according to the drug used in this study, there were no significant differences in the GCF levels of IL-1β and VEGF among the drug groups. Also, a significant gingival enlargement in the patient population was not recorded.
Conclusion. According to these results, it may be suggested that patients need optimal oral care in epilepsy.

Key words

children, epilepsy, cytokine, gingival crevicular fluid, oral health

Słowa kluczowe

dzieci, epilepsja, cytokiny, płyn dziąsłowy, higiena jamy ustnej

References (30)

  1. World Health Organisation (WHO) Atlas. Epilepsy care in the world. WHO, Geneva, 2005.
  2. Pitkanen A, Sutula TP. Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy. Lancet Neu-rol. 2002;1:173–181.
  3. Modeer T, Domeij H, Anduren I, Mustafa M, Brunius G. Effect of phenytoin on the production of interleukin-6 and interleukin-8 in human gingival fibroblasts. J Oral Pathol Med. 2000;29:491–499.
  4. Vahabi S, Salman BN, Rezazadeh F, Namdari M. Effects of cyclosporine and phenytoin on biomarker expressions in gingival fibroblasts of children and adults: An in vitro study. J Basic Clin Physiol Pharmacol. 2014;25:167–173.
  5. Horowitz MC. Cytokines and estrogen in bone: Anti-osteoporotics effects. Sci. 1993;260:626–627.
  6. Dagmar SP, Meley J. Interleukin-1β concentration of gingival crevicular fluid. J Periodontol. 1994;65:423–428.
  7. Vezzani A, Moneta D, Richichi C, et al. Functional role of inflammatory cytokines and antiinflammatory molecules in seizures and epilepto-genesis. Epilepsia 2002;43 Suppl. 5:30–35.
  8. Allan SM, Rothwell NJ. Cytokines and acute neurodegeneration. Nat Rev Neurosci. 2001;2:734–744.
  9. Murashima YL, Suzuki J, Yoshii M. Role of cytokines during epileptogenesis and in the transition from the interictal to the ictal state in the epileptic mutant EL mouse. Gene Regul Syst Bio. 2008;2:267–274.
  10. Lamster IB, Grbic JT. Diagnosis of periodontal disease based on analysis of the host response. Periodontol. 2000;1995:7, 83–99.
  11. Ebersole JL, Singer RE, Steffensen B, Filloon T, Kornman KS. Inflammatory mediators and immunoglobulins in GCF from healthy, gingivitis and periodontitis sites. J Periodont Res. 1993;28:543–546.
  12. Sakai A, Ohshima M, Sugano N, Otsuka K, Ito K. Profiling the cytokines in gingival crevicular fluid using a cytokine antibody array. J Periodontol. 2006;77:856–864.
  13. Unlu F, Guneri PG, Hekimgil M, Yesilbek B, Boyacioglu H. Expression of vascular endothelial growth factor in human periodontal tissues: Comparison of healthy and diabetic patients. J Periodontol. 2003;74:181–187.
  14. Prapulla DV, Sujatha PB, Pradeep AR. Gingival crevicular fluid VEGF levels in periodontal health and disease. J Periodontol. 2007;78:1783–1787.
  15. Ishihara Y, Nishihara T, Kuroyanagi T, et al. Gingival crevicular interleukin-1 and interleukin-1 receptor antagonist levels in periodontally healthy and diseased sites. J Periodont Res. 1997;32:524–529.
  16. Suthin K, Matsushita K, Machigashira M, et al. Enhanced expression of vascular endothelial growth factor by periodontal pathogens in gingi-val fibroblasts. J Periodont Res. 2003;38:90–96.
  17. Guneri P, Unlu F, Yesilbek B, et al. Vascular endothelial growth factor in gingival tissues and crevicular fluids of diabetic and healthy perio-dontal patients. J Periodontol. 2004;75:91–97.
  18. Booth V, Young S, Cruchley A, Taichman NS, Paleolog E. Vascular endothelial growth factor in human periodontal disease. J Periodont Res. 1998;33:491–499.
  19. Ben-Av P, Crofford LJ, Wilder RL, Hla T. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: A potential mechanism for inflammatory angiogenesis. FEBS Lett. 1995;372:83–87.
  20. Silness J, Loe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand. 1964;22:121–135.
  21. Loe H. The Gingival Index, the Plaque Index and the Retention Index Systems. J Periodontol. 1967, 38, Suppl, 610–616.
  22. Rigau V, Morin M, Rousset MC, et al. Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy. Brain 2007;130:1942–1956.
  23. Kim JE, Choi HC, Song HK, et al. Levetiracetam inhibits interleukin-1 beta inflammatory responses in the hippocampus and piriform cortex of epileptic rats. Neurosci Lett. 2010;471:94–99.
  24. Higuchi S, Yano A, Takai S, et al. Metabolic activation and inflammation reactions involved in carbamazepine-induced liver injury. Toxicolog Sci. 2012;130:4–16.
  25. Polverini PJ. The pathophysiology of angiogenesis. Crit Rev Oral Biol Med. 1995;6:230–247.
  26. Loe H, Holm-Pedersen P. Absence and presence of fluid from normal and inflamed gingivae. Periodont. 1965;149:171–177.
  27. Gurbuz T, Tan H. Oral health status in epileptic children. Pediatr Internat. 2010;52:279–283.
  28. Tan H, Gurbuz T, Dagsuyu IM. Gingival enlargement in children treated with antiepileptics. J Child Neurol. 2004;19:958–963.
  29. Sandalli P, Wade AB. Crevicular fluid flow in young children. J Periodontol. 1971, 42, 713–716.
  30. Yucel OO, Berker E, Gariboglu S, Otlu H. Interleukin-11, interleukin-1beta, interleukin-12 and the pathogenesis of inflammatory periodontal diseases. J Clin Periodontol. 2008, 35, 365–370.